JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M413865200 on January 5, 2005

J. Biol. Chem., Vol. 280, Issue 11, 10509-10515, March 18, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/11/10509    most recent
M413865200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shin, J. N.
Right arrow Articles by Kim, T.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shin, J. N.
Right arrow Articles by Kim, T.-H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cisplatin Inactivation of Caspases Inhibits Death Ligand-induced Cell Death in Vitro and Fulminant Liver Damage in Mice*

Jin Na Shin{ddagger}§, Young Woo Seo¶, Moonil Kim||, Sun-Young Park{ddagger}, Mi-Ja Lee**, Byung Rai Lee{ddagger}, Jae-Wook Oh§{ddagger}{ddagger}, Dai-Wu Seol||, and Tae-Hyoung Kim{ddagger}§§§

From the {ddagger}Department of Biochemistry, {ddagger}{ddagger}Anatomy, **Pathology, and §Medical Science and Engineering Research Center for Resistant Cells, Chosun University School of Medicine, 375 Seosuk-Dong, Dong-Gu, Gwangju, 501-759, Korea, the Korea Basic Science Institute Gwang-Ju Branch, Chonnam National University 300 Yongbong-Dong, Buk-Gu, Gwang-Ju, 500-757, Korea, and the ||Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261

Cisplatin is a platinum-containing chemotherapeutic drug that has been widely used to treat various human cancers. It acts by forming inter- and intracross-links of DNA, which is believed to be a major cause for its therapeutic efficacy. However, little attention has been paid to the effect of cisplatin on death ligand-induced cell death. Here we demonstrate that cisplatin inhibits death ligand-induced cell death in cell lines in a p53-independent manner. This inhibitory effect of cisplatin on cell death is direct, whereby cisplatin forms a complex with caspases leading to their inactivation. The cisplatin-caspase complex is reversed by the addition of reducing agent dithiothreitol, and caspase activity is regained. In addition, cisplatin shows a death-inhibition effect in in vivo animal models of fulminant liver damage induced by Fas activation and lipopolysaccharide-induced liver shock mediated by tumor necrosis factor-{alpha}. Together, we demonstrate that cisplatin inhibits cell death induced by death ligands in cell lines and in mice through caspase inactivation.


Received for publication, December 9, 2004

* This work was supported by Grant R13-2003-009-01002-0 from the Research Center for Resistant Cells (Medical and Engineering Research Center at Chosun University School of Medicine) funded by the Korea Science and Engineering Foundation (to T.-H. K. and J.-W. O.) and by a Grant R05-2003-000-10430-0 from the Korea Science and Engineering Foundation (to T.-H. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§§ To whom correspondence should be addressed: Rm. 2205, 2nd Floor of New Medical Bldg., Dept. of Biochemistry and Molecular Biology, Chosun University School of Medicine, 375 Seosuk-Dong, Dong-Gu, Gwangju, 501-759, Korea. Tel.: 82-62-230-6294; Fax: 82-62-226-4165; E-mail: thkim65{at}mail.chosun.ac.kr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
C.-Y. Han, K.-B. Cho, H.-S. Choi, H.-K. Han, and K.-W. Kang
Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells
Carcinogenesis, September 1, 2008; 29(9): 1837 - 1844.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. Ragunathan, J. Dairou, B. Pluvinage, M. Martins, E. Petit, N. Janel, J.-M. Dupret, and F. Rodrigues-Lima
Identification of the Xenobiotic-Metabolizing Enzyme Arylamine N-Acetyltransferase 1 as a New Target of Cisplatin in Breast Cancer Cells: Molecular and Cellular Mechanisms of Inhibition
Mol. Pharmacol., June 1, 2008; 73(6): 1761 - 1768.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.